
"There are probably more registered clinical trials now in Alzheimer's than in the entire history of the field," Relkin said. "It reflects this incredible Wild West attitude that there are no targets not to shoot at. All of these different avenues are being explored." To continue reading go here.
A new Alzheimer's treatment in an old remedy?
The study compared 847 people who were given at least one treatment of intravenous immunoglobulin over four years and 84,700 similar people who were not given the treatment. The records were pulled from a database of 20 million people age 65 and older. Those who received the immunoglobulin had a 42% lower risk of developing Alzheimer's disease over four years compared to those who did not receive the drug. To continue reading go here.
Alzheimer's Drugs May Be Next Investment Trend
After heart disease and cancer, Alzheimer's is the third-largest killer in the U.S. Care and treatment of the disease in the U.S. costs more than $100 billion annually. This is a big market that is only going to get bigger with the rise in instances of the disease To continue reading go here.
Love drives husband caring for wife with Alzheimer's
In 2006, Edward said that if his wife got to the point where she couldn't walk or respond he would consider a care facility. Now, he just says a little prayer and keeps going. To continue reading go here.
Idaho chapter of Alzheimer's group closes
As the United States sits on the cusp of a significant increase in people suffering from Alzheimer's disease and other forms of dementia - due to the aging of the Baby Boomer generation - the Alzheimer's Association of Greater Idaho closed its Boise office last week. To continue reading go here.
Subscribe to the Alzheimer's Reading Room
Bob DeMarco is an Alzheimer's caregiver and editor of the Alzheimer's Reading Room. The Alzheimer's Reading Room is the number one website on the Internet for advice and insight into Alzheimer's disease. Bob taught at the University of Georgia, was an executive at Bear Stearns, the CEO of IP Group, and is a mentor. He has written more than 700 articles with more than 18,000 links on the Internet. Bob resides in Delray Beach, FL.
More from the Alzheimer's Reading Room
- The Alzheimer's Reading Room--Press Release
- Test Your Memory (TYM) for Alzheimer's or Dementia in Five Minutes
- Questions About Test Your Memory (TYM) for Alzheimers and Dementia
- Dimebon Clinical Trial?
- The Thyroid and Alzheimer's
- Are Alzheimer's Caregivers the Forgotten?
- Flavanol-rich Cocoa Consumption Improves Blood Flow to the Brain
- A Simple Three Minute Test Can Detect the Earliest Stage of Alzheimer's Disease
- Eli Lilly Launches Two Late Stage Clinical Trials for Alzheimer's (LY2062430)
- Is it Really Alzheimer's or Something Else?
- Wii a Useful Tool for Alzheimer's Caregivers
- Five Ways to Keep Alzheimer's Away
- 2009 Alzheimer's Disease Facts and Figures
- The Mini-Cog Test for Alzheimer's and Dementia
- What is Dementia?
- A Real Solution to the Health Care Crisis
- 80 Percent of Medical Bills Contain Errors -- Fighting Mistakes